Pure Global

What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials - Trial NCT06326242

Access comprehensive clinical trial information for NCT06326242 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Solid Tumor. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06326242
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT06326242
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
Toward a Patient-centered Early Drug Development in Oncology: What Unmet Need for the Patients? A Focus on the Social Determinants of Health in Phase 1 Clinical Trials

Study Focus

Solid Tumor

Solid Tumor

Observational

other

Sponsor & Location

European Institute of Oncology

Milano, Italy

Timeline & Enrollment

N/A

Mar 27, 2023

Dec 31, 2024

100 participants

Primary Outcome

The geographical accessibility of patients attending the Phase 1 facility of the European Institute of Oncology (IEO).

Summary

An observational prospective study of patients enrolled and treated with experimental drugs
 in Phase I studies.

ICD-10 Classifications

Malignant neoplasm: Connective and soft tissue, unspecified
Carcinoma in situ, unspecified
Malignant neoplasm: Parametrium
Malignant neoplasm of other connective and soft tissue
Malignant neoplasm: Lip, unspecified, inner aspect

Data Source

ClinicalTrials.gov

NCT06326242

Non-Device Trial